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Serratia marcescens is a Gram-negative bacterium that thrives in a wide variety of ambient niches and interacts with an ample
range of hosts. As an opportunistic human pathogen, it has increased its clinical incidence in recent years, being responsible for
life-threatening nosocomial infections. S. marcescens produces numerous exoproteins with toxic effects, including the ShlA
pore-forming toxin, which has been catalogued as its most potent cytotoxin. However, the regulatory mechanisms that govern
ShlA expression, as well as its action toward the host, have remained unclear. We have shown that S. marcescens elicits an au-
tophagic response in host nonphagocytic cells. In this work, we determine that the expression of ShlA is responsible for the au-
tophagic response that is promoted prior to bacterial internalization in epithelial cells. We show that a strain unable to express
ShlA is no longer able to induce this autophagic mechanism, while heterologous expression of ShlA/ShlB suffices to confer on
noninvasive Escherichia coli the capacity to trigger autophagy. We also demonstrate that shlBA harbors a binding motif for the
RcsB regulator in its promoter region. RcsB-dependent control of shlBA constitutes a feed-forward regulatory mechanism that
allows interplay with flagellar-biogenesis regulation. At the top of the circuit, activated RcsB downregulates expression of flagella
by binding to the flhDC promoter region, preventing FliA-activated transcription of shlBA. Simultaneously, RcsB interaction
within the shlBA promoter represses ShlA expression. This circuit offers multiple access points to fine-tune ShlA production.
These findings also strengthen the case for an RcsB role in orchestrating the expression of Serratia virulence factors.
Serratia marcescens is a highly ubiquitous Gram-negative en-teric bacterium that can be isolated frommost abiotic environ-
mental sources (air, soil, andwater), as well as fromplants, insects,
and nematodes. In the clinical setting, together with the Serratia
liquefaciens complex (Serratia liquefaciens, Serratia proteamacu-
lans, and Serratia grimesii), S. marcescens causes the majority of
human Serratia infections and is the cause of urinary tract, respi-
ratory, wound, ocular, cardiac, bloodstream, and surgical infec-
tions, mostly affecting intensive care unit patients (1). Its capacity
to adhere and persist attached to hospital instrumentation and
prostheses (2); its resistance to disinfection procedures; and the
increasingly reported acquisition of resistance to lactams, cepha-
losporins, and aminoglycosides (1, 3) make S. marcescens a cur-
rent health threat worldwide. However, no clear picture of the
mechanisms that allow Serratia to succeed in the infected host has
yet emerged.
In our previous work, we have demonstrated that S.marcescens
is able to be internalized by nonphagocytic cells. We showed that,
once inside the cell, Serratia is able to inhabit andproliferate inside
large membrane-bound compartments. These vesicles exhibit au-
tophagic-like features, as they acquire markers typically recruited
throughout the progression of autophagosome biogenesis in the
antibacterial process (4). However, themajority of the autophagic
Serratia-containing vacuole population is nonacidic and has no
degradative properties, indicating alteration of the normal deliv-
ery to lysosomal compartments. These results reveal that Serratia
maneuvers the normal progression of host cell traffic, and they
contribute to explaining the potential for Serratia to establish in-
fection and persist in the host (4).
We demonstrated that flagellar expression was essential for the
bacteria to adhere to epithelial cells and that this contact was re-
quired for subsequent internalization in nonphagocytic cells, sug-
gesting that Serratia flagellar apparatus components can act as
adhesins (4). Interestingly, when a mutant strain impeded in fla-
gellum expression (flhDC) was coincubated with epithelial cells,
early onset of the autophagic process was induced in the whole
cultured epithelial cell layer, identical to the one induced by the
wild-type (wt) strain. Moreover, heat-killed bacteria were unable
to induce autophagy, and treatment of Serratia with chloram-
phenicol strongly diminished its ability to promote autophagy
from the outside of the eukaryotic cells (4). These results indicated
that an actively synthesized protein factor, most likely an exopro-
tein, was engaged in triggering autophagy prior to invasion.
In this work, we demonstrate that the expression of ShlA is
required to provoke the extracellular induction of autophagy that
takes place before S. marcescens is internalized in epithelial cells.
ShlA is a pore-forming toxin that belongs to the two-partner se-
cretion (also known as type Vb secretion [5]) family and is en-
coded by the shlBA operon (6, 7). Two-partner secretion (Tps)
systems are composed of two cognate components: a -barrel
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protein (in this system, ShlB) that is inserted in the outer bacterial
membrane and serves as the translocator of the active component,
in this case ShlA. ShlB not only secretes, but also mediates the
activation of ShlA (8, 9). Several works have supported the notion
that ShlA is a dominant factor in the virulence program of S.
marcescens: ShlA was shown to exert cytotoxic effects on epithelial
cells and fibroblasts (10), and shlBA mutant strains were highly
attenuated in mice, Caenorhabditis elegans, and Drosophila mela-
nogaster invasion models (11–13). Our findings reveal that ShlA
induces an autophagic process that would aid in shaping the fea-
tures of the vacuole, where the bacterium survives and prolifer-
ates. Therefore, they shed light on the relevance of this toxin in the
development of Serratia infection in diverse host organisms.
Earlier work from our group pointed to the S. marcescens Rcs
system as a key player in the regulation of the expression of viru-
lence determinants of the bacterium. The Rcs system constitutes a
signal transduction phosphorelay that was first identified in Esch-
erichia coli as the regulator of capsule synthesis (14). The system is
composed of two inner membrane sensor proteins of the two-
component family RcsC and RcsD and an associated transcrip-
tional response regulator, RcsB. Depending on its phoshorylation
status, RcsB binds to the promoter regions of its target genes,
activating or repressing their transcription. Three additional com-
ponents, RcsF, a membrane-anchored lipoprotein that can chan-
nel stimuli to the RcsC sensor; IgaA, which is able to repress RcsC
activity; and RcsA, which coregulates a set of genes, together with
RcsB, can be part of the Rcs signaling cascade (14, 15). We have
previously demonstrated that the Rcs system is able to modulate
swimming and swarming, the two motile capacities of Serratia
that depend on a functional flagellum. This regulation is due to
RcsB transcriptional control of the expression of flhDC, which
encodes the master regulator of the flagellar biogenesis transcrip-
tional cascade, FlhDC (16). The S. marcescens RcsF/RcsCDB sig-
naling cascade is activated by the deficiency of the enterobacterial
common antigen (ECA), an exopolysaccharidic structure assem-
bled by the wec cluster-encoded enzymes, provoking RcsB-medi-
ated inhibition of flhDC expression (16, 17). Concomitantly, we
found that, in S. marcescens, RcsB is also involved in the thermo-
regulated production of outer membrane vesicles (OMVs), which
pack and deliver a specific cargo of potential virulence determi-
nants, including lipolytic, proteolytic, and chitinolytic enzymes
(18).
In this work, we demonstrate that RcsB is able to exert control
of the expression of the shlBA operon in a coherent feed-forward
regulatory circuit that involves the flagellar regulatory cascade.
These results not only highlight the implication of RcsB in the
control of the expression of Serratia virulence traits, but also reveal
a finely tuned regulatory network required to control the produc-
tion of ShlA, an S. marcescens dominant pathogenic factor.
MATERIALS AND METHODS
Materials. -Minimal essential medium (-MEM) was obtained from
Invitrogen (Argentina). Fetal calf serum (FCS) was obtained from Inter-
negocios S.A. The antibiotics kanamycin (50 g/ml), ampicillin (100 g/
ml), chloramphenicol (20 g/ml), spectinomycin (100 g/ml), and gen-
tamicin (30 g/ml) were provided by Sigma (Argentina).
Rabbit anti-S. marcescens polyclonal antibodies were prepared in our
laboratory, and the secondary goat anti-rabbit IgG(HL) antibodies con-
jugated with Cy3 were provided by Zymed Laboratories.
Bacterial strains and plasmids. The strains and plasmids used in this
study are listed in Table 1.
Plasmid pES14 was kindly provided by Silke I. Patzer (Max Planck
Institute for Developmental Biology, Tuebingen, Germany) and was in-
troduced into competent E. coliW3110 and E. coli BL21(DE3) pLysS cells
by electroporation.
S. marcescens shlB was disrupted by integration of the suicide plasmid
pKNOCK-Spr, derived from plasmid pKNOCK-Gm (19). Briefly, an in-
ternal fragment of 460 bp from the shlB gene was amplified by PCR using
primers FwmutShlB (BamHI) and RvmutShlB (XhoI) (Table 2). The pu-
rified PCR product was digested with the BamHI and XhoI restriction
enzymes, and the fragment was ligated into the BamHI and XhoI sites of
pKNOCK-GmR. Then, the gentamicin cassette was interrupted by liga-
tion to a spectinomycin cassette (20) in the BglII site. The resulting plas-
mid was introduced into competent E. coli SM10 (pir) cells by electropo-
ration and then mobilized into the S. marcescens wild-type strain by
conjugation. Insertional mutants were confirmed by PCR analysis. For
complementing S. marcescens shlB, pES14 was digested with EcoRI and
HindIII restriction enzymes, and the operon shlBA was ligated into the
EcoRI and HindIII sites of pBBR1-MCS2 Kmr. The resulting plasmid was
mobilized into S. marcescens shlB by conjugation.
S. marcescens fliA was disrupted by integration of the suicide plasmid
pKNOCK-Cmr (19). Briefly, an internal fragment of 692 bp from the gene
fliA was amplified by PCR using primers FliAserratiaNter and FliActer-
revserratia (Table 2). The purified PCR product was digested with the
NarI restriction enzyme, and a fragment of 350 bpwas ligated into theClaI
site of pKNOCK-Cmr. The resulting plasmid was introduced into com-
petent E. coli SM10 (pir) cells by electroporation and thenmobilized into
the S. marcescens wild-type strain by conjugation. Insertional mutants
were confirmed by PCR analysis. For complementing S. marcescens fliA,
pBBR1-MCS2 Kmr was digested with XhoI, and the 5= overhanging end
was filled by treatmentwithKlenow fragment. Finally, it was digestedwith
the HindIII restriction enzyme. fliA was amplified by PCR using primers
FliA-serratia-Nter and FliA-cter-rev-serratia, and the purified PCR prod-
uct was digested with the SmaI and HindIII restriction enzymes. The
fragment was ligated into pBBR1-MCS2 Kmr, and the resulting plasmid
was mobilized into S. marcescens by conjugation.
The S. marcescens phlA rcsB and phlA shlB strains were constructed
through the mobilization of plasmids rcsB::pKNOCK-GmR and shlB::
pKNOCK-Spr, respectively, into the S. marcescens phlA strain by conjuga-
tion.
To analyze the transcriptional level of shlBA, the promoter region of
the operon was amplified by PCR using the primers Prom ShlBFwEcoRI
and PromShlBRvBamHi (Table 2). The purified PCR product was di-
gested with the EcoRI and BamHI restriction enzymes and was ligated
into the same sites of pBBR1-MCS2 Kmr. The resulting plasmid was in-
troduced into competent E. coli XL1-Blue cells by electroporation, and
then it was digested with HindIII and BamHI restriction enzymes. The
purified fragment of 539 bp was ligated into the same sites of
pPROBE(NT) (21) and introduced into competent E. coli XL1-Blue cells
by electroporation. The plasmid ppromshlBA-gfp was mobilized by con-
jugation into the S. marcescens wild-type strain and the fliA, flhD, wecG,
and rcsB mutant strains.
To construct the pBB1 lacI::rcsB Cmr and pBB5::rcsB GmR plasmids,
the rcsB gene was amplified from the S. marcescens wild-type strain chro-
mosome by PCR, using primers RcsBFwXhoI and RcsBRvBamHI (Table
2). The PCR product was cloned into the XhoI-BamHI-digested pBBR1-
MCS1 Cmr and pBBR1-MCS5 GmR plasmids. The resulting plasmids
were mobilized into bacterial strains by conjugation.
Bacterial and cell culture. Bacteria were routinely grown in Miller=s
Luria-Bertani (LB) medium supplemented with antibiotics at 30°C or
37°C, as indicated.
Stably transfected Chinese hamster ovary (CHO) cells overexpressing
enhanced green fluorescent protein (EGFP)-LC3 (CHO-EGFP-LC3)
were grown in-MEMsupplementedwith 10%FCS at 37°C and 5%CO2.
Hemolysin activity assay. S. marcescens and E. coli strains were grown
overnight (ON) in LBmedium, without shaking, at 30°C or 37°C, respec-
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TABLE 1 Strains and plasmids used in this study
Strains and plasmids Genotype and/or comments Source or reference
S. marcescens
Wild type S. marcescens RM66262; clinical isolate 17
rcsB rcsB::pKNOCK-Gmr 16
rcsA rcsA::pKNOCK- Gmr 16
rcsC rcsC::pKNOCK-Gmr 16
rcsF rcsF::pKNOCK-Gmr 16
fliA fliA::pKNOCK-Cmr This work
flhD flhD::pKNOCK-Cmr 4
shlB shlB::pKNOCK-Spr This work
wecG wecG::pKNOCK-Cmr 16
phlA phlAB::Cmr 17
wecG rcsB wecG::pKNOCK-Cm; mini-Tn5::rcsB; Kmr 16
phlA rcsB phlAB::Cm; rcsB::pKNOCK-Gmr This work
phlA shlB phlAB::Cm; shlB::pKNOCK-Spr This work
fliA/pBB2 fliA::pKNOCK-Cmr/pBB2; Kmr This work
flhD/pBB2 flhD::pKNOCK-Cmr/pBB2; Kmr This work
fliA/pBB2::fliA fliA::pKNOCK-Cmr/pBB2::fliA; Kmr This work
flhD/pBB2::flhDC flhD::pKNOCK-Cmr/pBB2::flhDC; Kmr 4
fliA/pBB2::flhDC fliA::pKNOCK-Cmr/pBB2::flhDC; Kmr This work
flhD/pBB2::fliA flhD::pKNOCK-Cmr/pBB2::fliA; Kmr This work
wt/pBB2 Wild-type strain/pBB2; Kmr This work
wt/pBB2::fliA Wild-type strain/pBB2::fliA; Kmr This work
wt/pBB2::flhDC Wild-type strain/pBB2::flhDC; Kmr This work
shlB/pBB2 shlB::pKNOCK-Spr/pBB2; Kmr This work
shlB/pBB2::fliA shlB::pKNOCK-Spr/pBB2::fliA; Kmr This work
shlB/pBB2::flhDC shlB::pKNOCK-Spr/pBB2::flhDC; Kmr This work
rcsB/pBB1 rcsB::pKNOCK-Gmr/pBB1 lacI; Cmr This work
rcsB/pBB1::rcsB rcsB::pKNOCK-Gmr/pBB1 lacI::rcsB; Cmr This work
fliA/pBB5 fliA::pKNOCK-Cmr/pBB5; Gmr This work
flhD/pBB5 flhD::pKNOCK-Cmr/pBB5; Gmr This work
fliA/pBB5::rcsB fliA::pKNOCK-Cmr/pBB5::rcsB; Gmr This work
flhD/pBB5::rcsB flhD::pKNOCK-Cmr/pBB5::rcsB; Gmr This work
wecG/pBB2 wecG::pKNOCK-Cmr/pBB2; Kmr This work
wecG/pBB2::fliA wecG::pKNOCK-Cmr/pBB2::fliA; Kmr This work
wecG/pBB2::flhDC wecG::pKNOCK-Cmr/pBB2::flhDC; Kmr This work
wt/ppromshlBA-gfp Wild-type/pPROBE(NT)::promshlBA; Kmr This work
fliA/ppromshlBA-gfp fliA::pKNOCKCmr/pPROBE(NT)::promshlBA; Kmr This work
flhD/ppromshlBA-gfp flhD::pKNOCK-Cmr/pPROBE(NT)::promshlBA; Kmr This work
wecG/ppromshlBA-gfp wecG::pKNOCK-Cmr/pPROBE(NT)::promshlBA; Kmr This work
rcsB/ppromshlBA-gfp rcsB::pKNOCK-Gmr/pPROBE(NT)::promshlBA; Kmr This work
E. coli
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lacTcR Stratagene
W3110  IN(rrnD-rrnE)1 rph-1 50
W3110/pT7 T7 overexpression vector; Ampr This work
W3110/pES14 pT7–5::shlBA; Ampr This work
W3110/pBB2 pBB2; Kmr This work
W3110/pphlAB pBB2::phlAB; Kmr This work
BL21(DE3), pLysS F ompT hsdSB(rB
mB
) gal dcm (DE3) pLysS(Cmr) Stratagene
Plasmids
pBB1 pBBR1-MCS1 Cmr; broad host range 51
pBB2 pBBR1-MCS2 Kmr; broad host range 51
pBB5 pBBR1-MCS5 Gmr; broad host range 51
pflhDC pBBR1-MCS2::flhDC; Kmr 4
pT7 T7 overexpression vector; Ampr 52
pES14 pT7-5:shlBA; Ampr 7
pphlAB pBBR1-MCS2::phlAB; Kmr 17
pBB2::shlBA pBBR1-MCS2::shlBA; Kmr This work
pBB1::rcsB pBBR1-MCS1::rcsB; Cmr This work
pBB5::rcsB pBBR1-MCS5::rcsB; Gmr This work
pBB2::fliA pBBR1-MCS2::fliA; Kmr This work
pBB2::flhDC pBBR1-MCS2::flhDC; Kmr 4
ppromshlBA-gfp pPROBE(NT)::promshlBA; Kmr This work
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tively, as indicated. Two hundred microliters of the bacterial suspension
was incubated with 200 l of a suspension of human red blood cells in
phosphate-buffered saline (PBS) for 1 h at 30°C. In another set of exper-
iments, overnight cultures of S. marcescens were diluted 1:100 in fresh LB
medium and cultivated for 3 h without agitation at 30°C. Dilutions (1:4)
of the exponential cultures were prepared with PBS, and a 200-l aliquot
of each hemolytic sample was incubated with 200 l of erythrocyte sus-
pension for 1 h at 30°C. After centrifugation, the amount of hemoglobin
released into the supernatant was determined bymeasuring absorbance at
562 nm. The absorbance of each sample was normalized to the optical
density at 600 nm (OD600) of the corresponding culture. The 100% activ-
ity level was determined by incubating 200 l of human red blood cells
with 200l of water. The relative activity was plotted, using the wild-type
strain hemolytic activity value as the unit.
Determination of ShlAprotein levels.Tenmilliliters of saturated cul-
tures grown in LBmedium at 30°Cwas centrifuged for 5min at 5,000	 g,
and the supernatant was separated. The spent medium was filtered with
0.2-m acetate-cellulose filters, precipitated with 12% trichloroacetic
acid for 30 min at 4°C, and centrifuged for 30 min at 30,000 	 g. The
precipitated proteins were resuspended in protein sample buffer. One
milliliter of trichloroacetic acid-precipitated spent medium was loaded
onto 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) gels. Hemolysin levels were determined byWestern blotting
using S. marcescens anti-ShlA rabbit polyclonal antibodies.
ShlA rabbit polyclonal antibodies. Hemolysin was purified as de-
scribed previously (22). Briefly, E. coli BL21(DE3), pLysS harboring the
pES14 plasmidwas grown in LBmediumat 37°C, and gene expressionwas
induced at an OD600 of 0.5 by addition of isopropyl thio--D-galactoside
(final concentration, 0.5 mM). After further incubation for 2 h, the cells
were sedimented (10,000	 g for 15min), and the supernatant containing
the ShlA protein was precipitated by addition of solid ammonium sulfate
(to 45% saturation) on ice. After 1 h of incubation at 0°C, the protein was
sedimented by centrifugation at 15,000 	 g (30 min; 4°C). The protein
was suspended in 1 ml buffer (50 mM HEPES, pH 8), and desalted on a
PD30 Sepharose column (GE Healthcare). The eluent was applied to a
Mono-S (HR 5/5) cation-exchange column (GEHealthcare) equilibrated
with HEPES buffer. The column was washed with 15 ml HEPES buffer,
and the bound proteins were eluted by a linear NaCl gradient (0 to 500
mM) in 25 ml HEPES buffer. Fractions of 1 ml were collected. The puri-
fied hemolysin was used to immunize New Zealand White rabbits, as
previously described (17).
Construction, expression, and purification of RcsB-His6. A
His	6-tagged RcsB protein (RcsB-His	6)-tagged fusion gene was con-
structed by PCR using primers rcsBHis pParalellNcoIFw (Table 2) and
rcsBHis-Parallel XhoIRv (Table 2) and then cloned into the NcoI and
XhoI sites of the pHisParallel vector (23) to obtain the plasmid pHisPar-
allel::orfrcsB-HisNter. RcsB-His	6 was expressed in E. coli BL21(DE3)
pLysS. Cells were grown in 500 ml of LB medium at 37°C to an OD600 of
0.5. Following induction with 0.25 M isopropyl--D-thiogalactopyra-
noside (IPTG) and incubation for 4 h at 25°C, cells were harvested and
disrupted by sonication. The RcsB-His	6 protein was purified using an
Ni2-nitrilotriacetic acid-agarose affinity chromatography column ac-
cording to theQIA expression purification protocol (Qiagen) and exhaus-
tively dialyzed against 20 mM Tris-HCl (pH 7.4), 500 mM NaCl. The
protein concentration was determined by a bicinchoninic acid assay (Bio-
Rad), and the protein profile of the purified RcsB-His	6 protein was
analyzed by SDS-PAGE (24).
DNase I footprinting assay.DNase I protection assayswere donewith
DNA fragments corresponding to the shlB and flhD promoter regions.
The DNA fragments were amplified by PCR using the appropriately 32-P-
labeled primers (PromShlBFwEcoRI, PromShlBRvBamHI, and Promflh-
DRv [Table 2]). Approximately 6.0 fmol of each DNA fragment was in-
cubated with purified RcsB-His	6 protein (see the legend to Fig. 6 for the
amounts) at room temperature for 30 min in a 20-l volume of binding
reaction mixture. The RcsB-His	6 protein was previously phosphory-
lated by incubation with acetyl phosphate (0.9 ng/l) at room tempera-
ture for 30 min. The binding buffer used for protein-DNA incubation
contained 25 mM Tris-HCl (pH 8), 50 mM NaCl, 5 mM MgCl2, 5 mM
dithiothreitol, 10% glycerol, 2.0 ng/l salmon sperm DNA, and 0.025
mg/ml bovine serum albumin. DNase I (0.05 U; Life Technologies, Inc.)
was added, and themixture was incubated for 90 s at room temperature in
a final volume of 100 l. The reaction was stopped by adding 90 l of 20
mM EDTA (pH 8.0) solution. DNA fragments were purified by phenol-
chloroform extraction and resuspended in 6.0 l of sequencing stop so-
lution buffer (10mMNaOH, 95% formamide, 0.05%bromophenol blue,
0.05% xylene cyanol). Samples were analyzed by denaturing polyacryl-
amide (6%) gel electrophoresis by comparison with a DNA sequence lad-
der generated with the appropriate primer. After electrophoresis, the gel
was dried and autoradiographed (25).
shlBA gene expression assays. Ten microliters of overnight LB me-
dium cultures of S. marcescens strains carrying ppromshlBA-gfp was
mixed with 1 ml of fresh LB medium with kanamycin, and 100 l of the
mixture was incubated in a 96-well black microtiter plate at 30°C without
agitation for 18 h. Fluorescence (excitation wavelength [exc]
 485 nm;
emission wavelength [em] 
 528 nm) and OD600 readings were deter-
mined every 60minwith a 96-microwell plate reader (Synergy2 or BioTek
ELx808 microplate reader). The means and standard deviations for trip-
licate analysis were calculated.
Autophagy assay. The autophagy assay was performed as a gentami-
cin protection assay (26) with modifications as follows. CHO-GFP-LC3
cells were cultured in 24-well plates until they reached 50% confluence. S.
marcescens or E. coli cultures were grown without shaking overnight at
30°C. The bacterial cultures were washed once with PBS, and an appro-
priate volume was added to each well to reach a multiplicity of infection
(MOI) of 10. The plates were centrifuged for 10 min at 1,000 rpm and
incubated for 1 h at 37°C and 5% CO2. Then, the cells were washed re-
peatedly with PBS and medium supplemented with 10% FCS, and 30
g/ml gentamicin was added, or in other set of experiments, the cells were
left without treatment. At the indicated time points, the cells were washed
four times with PBS and fixed with 0.5 ml 3% paraformaldehyde solution
in PBS.
Indirect immunofluorescence and confocal microscopy. Infected
cells overexpressing EGFP-LC3 were fixed with 0.5 ml of 3% paraformal-
dehyde solution in PBS for 10 min and permeabilized with 0.1% Triton
X-100 solution in PBS for 5 min. Subsequently, the cells were incubated
with primary polyclonal antibodies against S. marcescens (1:500) and de-
tected by incubation with anti-rabbit Cy3-conjugated secondary antibod-
ies (1:150). The cells were mounted with SlowFadeAntifade reagent in
glycerol-PBS (Molecular Probes). Finally, the cells were analyzed by con-
focal microscopy with a Nikon Eclipse TE-2000-E2 and the EZ-C1 3.20
Free Viewer program (Nikon, Japan). At least 200 cells from three inde-
















a Restriction sites are underlined.
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pendent experiments were scored using confocal microscopy. The per-
centage of colocalization was calculated as the ratio between the number
of internalized bacteria that colocalized with EGFP-LC3 and the total
number of infected cells.
Statistical analysis. Statistical analysis was performed using one-way
analysis of variance (ANOVA) and the Tukey-Kramer multiple-compar-
ison test with an overall significance level of 0.05. The asterisks in the plots
denote the values among the treatment groups for which a statistically
significant difference was determined.
RESULTS
ShlA is responsible for inducing autophagy in nonphagocytic
epithelial cells.Wepreviously determined that upon contact with
Serratia, an autophagic response was induced in epithelial cells
prior to bacterial internalization. Our results showed that, al-
though the flagellum is involved in early bacterium-host cell ad-
hesion, neither the flagellumnor the phospholipase PhlA, which is
dependent on the integrity of the flagellar structure for its secre-
tion, was the factor implicated in autophagy induction (4).
Hertle et al. (10) had previously shown that the recombinant
ShlA pore-forming toxin of S. marcescens produced in E. coli was
able to exert a cytotoxic action on human epithelial cells. They
attributed this effect to the capacity of ShlA to induce ATP deple-
tion and K efflux from epithelial cells, which was also observed
when fibroblasts were assayed. It was later demonstrated that K
efflux can promote the onset of the autophagic response (27–30).
In light of these results, we conjectured that ShlA could be the
virulence factor responsible for the induction of autophagy.
To test if the expression of the ShlA exoprotein was able to
induce autophagy, the shlBA operon was expressed from the
pES14 plasmid in the nonpathogenic E. coli strain W3110. The
expression and activity of ShlA in E. coli were verified by immu-
nodetection using anti-ShlA polyclonal antibodies and by the de-
termination of hemolytic activity using human red blood cells,
respectively, as described inMaterials andMethods (Fig. 1A). The
CHOcells expressing EGFP-LC3were challenged by coincubation
with either wild-type Serratia or the E. coli strain carrying the
empty vector or the shlBA-containing plasmid, followed by a pre-
viously set up gentamicin protection protocol (4). As expected, E.
coli W3110 was not able to invade CHO cells, and this behavior
was not altered when the strain carried the pES14 plasmid (data
not shown). The autophagy phenotype (revealed by the EGFP-
LC3 punctate pattern as opposed to the homogeneous distribu-
tion of green fluorescence in nontreated cells) was induced in
CHOcells expressing EGFP-LC3when eitherwild-type Serratiaor
the E. coli W3110/pES14 strain was used in the assay (Fig. 1B,
compare EGFP-LC3 fluorescence patterns in cells shown in im-
ages d and h to controls in images b and f). In agreement with our
previous results (4), no induction of autophagy was detected with
E. coli cells carrying either the empty vector or the pphlAB plas-
mid, used as controls for the assay (Fig. 1B, j and l). pphlBA har-
bors the phlAB operon that encodes phospholipase PhlA together
with PhlB, a protein which, in complex with PhlA, protects the
bacterial cell from lipolytic action before secretion (31). At 300
min postinfection (p.i.), in the absence of extracellular bacteria,
which were eliminated by gentamicin action, homogeneous cyto-
plasmic LC3 labeling was observed only in noninvaded cells. Con-
versely, cells evidencing the presence of intracellular Serratia
showed the characteristic LC3 dotted pattern (compare matching
panels in Fig. 1B and C). Figure 1D shows the percentage of cells
showing LC3 puncta calculated from each assay. These results
indicate that, when extracellular bacteria are no longer present,
autophagy occurs only in infected cells. We reason that in nonin-
vaded cells, and in the absence of an external stimulus, autopha-
gosome turnover provokes the clearance of the membrane-re-
cruited LC3 autophagic marker, which would be replaced by the
nonlipidated cytoplasmic form.
To confirm that ShlA was involved in the external activation of
autophagy, we constructed a Serratia mutant strain in which shlB
was disrupted by insertion of a spectinomycin resistance cassette
(shlB::Spr). Because shlBA is an operon (7) and ShlB is required for
ShlA activation and secretion, the shlB mutant strain was unable
to both activate and secrete the ShlA hemolysin. The lack of ShlA
expression and the hemolytic capacity of the shlB mutant strain
were verified by immunodetection and by measuring hemolytic
activity (Fig. 1A, compare wt and shlB). Challenged CHO
EGFP-LC3 cells were split in two, and extracellular bacteria were
either eliminated by gentamicin 60 min p.i. or left untreated. The
cells were then fixed, stained, and microscopically inspected 150
min p.i.
When the EGFP-LC3 CHO cell invasion assay was performed
with the shlBmutant strain, no LC3 puncta were detected in non-
invaded cells (Fig. 2A and B, compare shlB images). The capacity
of the shlB mutant strain to induce the autophagic phenotype, as
in the wild-type strains, was recovered when it was complemented
with the shlBA operon in trans (Fig. 2, h). In fact, the comple-
mented strain provoked a stronger punctate LC3-EGFP fluores-
cent pattern than the wild-type strain (Fig. 2A and B, compare
images d to h). This can be attributed to the high levels of ShlA
expressed from the plasmid that would accordingly lengthen the
stimulus effect and the time for LC3II to LC3I turnover (Fig. 2B,
h). Indeed, ShlA expression and hemolytic activity in the comple-
mented shlB/pBB2::shlBA strain was higher than that determined
for the wild-type strain (Fig. 1A). After gentamicin treatment,
either with the wild type or with the shlB mutant strain, LC3
puncta were only observed clustered in a restricted area tightly
surrounding the invading bacteria, while homogeneous LC3 dis-
tribution was observed in the rest of the CHO cell cytoplasm (Fig.
2B, d and f).
To further analyze whether externally induced autophagy pre-
cedes the intracellular formation of the autophagosome-like Ser-
ratia-containing vacuole (SeCV), we also scored the total number
of cells that showed LC3 puncta (Fig. 2A to C).When extracellular
bacteria were not eliminated by gentamicin, the cells that dis-
played the LC3 dotted pattern exceeded by 3.5-fold the scores
determined for gentamicin-treated cells, provided the bacteria ex-
pressed ShlA (Fig. 2A and C). As observed in the representative
captured images, even when gentamicin has eliminated extracel-
lular bacteria, the autophagic phenotype (evidenced by cells con-
taining LC3 puncta) was more persistent in noninvaded cells in
the case of the shlB/pBB2::shlBA strain compared to the wild-type
strain, due to high ShlA expression (Fig. 2B and C).We alsomon-
itored colocalization of Serratiawith LC3 at 120, 240, and 360min
p.i., following the gentamicin protection protocol (Fig. 2D). Once
internalization had taken place, the autophagic phenotype was
only observed associated with cells containing SeCVs. Although a
delaywas observed for the shlBmutant strain levels at 120min p.i.,
at 240 or at 360min, shlB reached numbers of cells containing LC3
puncta equivalent to those in the wild-type strain (Fig. 2D). To-
gether, these results indicate that when host cells are challenged
with Serratia, the vast majority of exposed cells undergo au-
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tophagy induction, and that this trigger depends on ShlA expres-
sion. Once internalization has occurred, ShlA is no longer essen-
tial to sustain LC3 recruitment to the SeCV within the invaded
cell, suggesting that bacterial effectors other that ShlA could be
involved in the autophagy process intracellularly.
ShlA is transcriptionallymodulated by RcsB. In light of these
results, we sought to gain insight into the regulatory mechanisms
that govern ShlA expression. We had shown that the flagellar bio-
genesis was transcriptionally modulated by the RcsCDB system,
with flhDC under negative regulation by RcsB (17). While analyz-
ing this mechanism, we concomitantly observed that the rcsBmu-
tant showed exacerbated hemolytic activity. Therefore, we hy-
pothesized that this increase could be due to a transcriptional
cascade involving the Rcs flagellar circuit under the control of
shlBA expression.
To examine this possibility, we assayed the hemolytic capaci-
ties of the S. marcescens flhD and fliAmutant strains compared to
the wild-type strain. In both mutant strains, we observed a partial
FIG 1 S. marcescens ShlA induces autophagy in CHO cells. (A) S. marcescens or E. coli strains were grownON, without shaking, at 30°C or 37°C, respectively. The
saturated cultures were centrifuged, and the supernatant was filtered with 0.2 m acetate-cellulose filters, precipitated with 12% trichloroacetic acid, and
centrifuged for 30 min at 30,000	 g. The precipitated proteins were resuspended in protein sample buffer and loaded onto SDS-PAGE gels. Hemolysin levels
were determined by Western blotting using S. marcescens anti-ShlA rabbit polyclonal antibodies. To determine the hemolytic activity, 200 l of the bacterial
suspension was incubated with 200 l of a human red blood cell suspension for 1 h at 30°C. The amount of released hemoglobin in the supernatant was
determined bymeasuring absorbance at 562 nm. The absorbance of each sample was normalized to the OD600 of the corresponding culture. Relative activity was
plotted by considering the wild-type strain hemolytic activity value as the unit. The averages and standard deviations (SD) are shown for four independent
experiments performed in duplicate in each case. Statistical analysis was performed using one-way ANOVA and the Tukey-Kramermultiple-comparison test. **,
P 0.01; ***, P 0.001; statistically significantly different from wild-type S. marcescens. At the top are shown representative images of the immunodetection
assay; each lane corresponds to the sample analyzed for hemolytic activity in the plot below. (B and C) CHO-EGFP-LC3 cells were infected with wild-type S.
marcescens (c and d) or with noninvasive E. coliW3110/pT7 (e and f), E. coliW3110/pES14 (g and h), E. coliW3110/pBB2 (i and j), or E. coliW3110/pphlAB (k
and l) and fixed at 120 min p.i. (B) or treated with gentamicin and fixed at 300 min p.i. (C). Noninfected cells are shown as a control (a and b). The cells were
visualized by confocal microscopy. Representative differential interference contrast (DIC) and green fluorescence from EGFP-LC3 images are shown. Bars, 10
m. (D) Quantitative measurement of the autophagy assay. CHO-EGFP-LC3 cells subjected to the assay depicted in panels B and C were visualized by confocal
microscopy. At least 300 infected cells were counted for each condition. The averages and SD are shown for three independent experiments performed in
duplicate in each case. Statistical analysis was performed using one-way ANOVA and the Tukey-Kramer multiple-comparison test. ***, P 0.001.
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decrease (ca. 50% reduction) in hemolytic activity levels that was
restored to the wild-type level when FlhDC or FliA was expressed
in trans from the pBB2::flhDC or pBB2::fliA plasmid, respectively
(Fig. 3A). Overexpression of FliA or FlhDC in the wild-type back-
ground rendered up to 2-fold-increased hemolytic activity levels
compared to those attained in the wild-type strain (Fig. 3A). We
also overexpressed FliA or FlhDC in an shlB mutant strain. As
shown in Fig. 3A, no induction of a second hemolytic activity was
detected in these strains. Together, these results indicated an in-
ducing action of the flagellar regulatory cascade over shlA expres-
sion. On the other hand, the rcsB mutant strain showed a 2-fold
increase in hemolytic capacity relative to the wild-type strain
(Fig. 3B).
A strong (5-fold) reduction in hemolytic activity was detected
when an Rcs-inducing condition, i.e., awecGmutant background
in which ECA assembly is impaired (16, 17), was used in the assay.
Under this condition, we obtained hemolytic levels similar to
those measured for the shlB strain (Fig. 3B). As expected, the he-
molytic capacity of the wecGmutant was restored to rcsB levels in
a wecG rcsB double-mutant strain (Fig. 3B). Moreover, the over-
expression of RcsB inhibited hemolytic activity in either an flhD or
an fliA mutant background (Fig. 3B). In accordance with this re-
sult, neither pBB2::flhDC nor pBB2::fliA could complement a
wecG mutant strain (Fig. 3B, wecG/pBB2::fliA and wecG/pBB2::
flhDC). In addition, no effect was detected when an rcsA, rcsF, or
rcsC genetic background was compared to the wild type (Fig. 3C,
compare wt with rcsA, rcsF, and rcsC hemolytic levels). Therefore,
our results indicate that RcsB downregulates hemolysin expres-
sion. They also provide evidence that RcsB inhibitory action can
be exerted, bypassing the flagellar regulatory cascade, and that
under the assayed conditions, RcsF/RcsC/RcsA signaling compo-
nents have no role in the control of ShlA expression levels.
Previous work showed that the expression of the PhlA phos-
pholipase is activated by FliA and that PhlA secretion depends on
the integrity of the type III flagellar secretory apparatus (32). Fur-
thermore, it was shown that PhlA was able to cause cell lysis in the
presence of phospholipids (33). Therefore, to rule out the possi-
bility that PhlA expression could be partially responsible for the
observed induction of the cytolytic activity mediated by the acti-
vation of the flagellar cascade, a phlAmutant strainwas also tested.
As shown in Fig. 3D, hemolytic activity levels measured in a wild-
type, rcsB, or shlB background were not affected by the deletion of
phlA. The functionality of pBB2::flhDC and pBB2::fliA in the com-
plementation of flhD or fliAmutant strains, as well as the effects of
FlhDC and FliA overexpression in the wild-type strain back-
ground, was also examined by immunodetection of flagellin ex-
FIG 2 A Serratiamutant strain impeded in ShlA expression is unable to trigger autophagy from the extracellular space. CHO-EGFP-LC3 cells were infected with
wild-type S. marcescens (c and d), the S. marcescens shlB strain (e and f), or the S. marcescens shlB/pBB2::shlBA strain (g and h) and fixed at 150 min p.i. (A) or
treated with gentamicin and fixed at 150 min p.i. (B). Noninfected cells are shown as a control (a and b). The cells were visualized by confocal microscopy.
Representative DIC andmerged fluorescence images, green for EGFP-LC3 and red for bacteria, are shown. Bars, 10 m. (C) CHO-EGFP-LC3 cells subjected to
the assay depicted in panels A and Bwere visualized by confocal microscopy. At least 300 infected cells were counted for each condition. The averages and SD are
shown for three independent experiments performed in duplicate in each case. Statistical analysis was performed using one-way ANOVA and the Tukey-Kramer
multiple-comparison test. *, P 0.05; **, P 0.01; ***, P 0.001; statistically significantly different from wild-type S. marcescens. (D) CHO-EGFP-LC3 cells
were infected with wild-type S. marcescens or the S. marcescens shlB strain and treated with gentamicin at 60 min p.i. and fixed at the indicated times. The
percentages of colocalization of bacteria with EGFP-LC3 were determined by confocal microscopy. At least 300 infected cells were counted for each condition.
The averages and SD are shown for three independent experiments performed in triplicate in each case. Statistical analysis was performed using one-wayANOVA
and the Tukey-Kramer multiple-comparison test. ***, P 0.001; statistically significantly different from wild-type S. marcescens.
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pression (Fig. 3E). This assay confirmed the proper functional
expression of both flagellar transcriptional regulators from the
pBB2 plasmids.
To analyze the observed regulatory effects at the transcrip-
tional level, we monitored shlBA gene expression profiles by
detecting fluorescence over time from a ppromshlBA-gfp tran-
scriptional reporter in the aforementioned mutant genetic back-
grounds. ppromshlBA harbors 539 bp that comprise 500 bp up-
stream of the shlB ATG initiation codon and 39 bp of the shlB
coding region fused to the green fluorescent protein (GFP)-en-
coding gene (see plasmid construction details in Materials and
Methods). As shown in Fig. 4, and in good correlation with the
hemolytic activity results (Fig. 3A and B), shlBA expression was
repressed in thefliAorflhD strains andwas further inhibited in the
wecGmutant background, while strong activation was detected in
an rcsB strain compared to the wild-type strain. The fact that at 16
h fliA or flhD mutants reached wild-type transcriptional activity
levels shows that, as has also been demonstrated by the results
fromhemolytic activitymeasurements (Fig. 3A), FliA control over
shlBA expression is not an on-off regulation. Therefore, we can
infer that shlBA expression can also be directed by other transcrip-
tional factors, such as Fur (34), depending on the growth phase or
environmental conditions of the bacterial culture. Together, our
results provide evidence that, in addition to the repression chan-
neled by the FlhDC/FliA-dependent circuit, RcsB is also able to
exert direct inhibition of shlBA expression.
A bioinformatics search for a putative RcsB-binding site in the
shlBA promoter region by use of the MEME/MAST motif detec-
tion programs (35, 36) showed the presence of a putative RcsB-
binding motif 254 bp upstream of the shlB ATG initiation codon
(Fig. 5A). To assess RcsB direct binding to the promoter region of
shlBA, a DNase I footprinting assay was performed using purified
FIG3 Modulation of hemolytic activity by the flagellar regulatory cascade and the Rcs system. The hemolytic activity of each S.marcescens strain was determined
by hemolysis assay in liquid culture. Log-phase cells (A600
 0.25), grown at 30°C in liquid LB medium without agitation, were harvested, resuspended in PBS
buffer, and incubated at 30°C with an equal volume of erythrocytes, as described in Materials and Methods. Hemolytic activity values (relative units) were
calculated relative to the hemolytic activity of the wild-type strain, considered the unit. The averages and SD are shown for four independent experiments
performed in duplicate in each case. Statistical analysis was performed using one-way ANOVA and the Tukey-Kramermultiple-comparison test. ***, P 0.001;
statistically significantly different from wild-type S. marcescens. (A) Hemolytic activity of wild-type, fliA, flhD, and shlBmutant strains and the strains harboring
either the empty vector or pBB2::fliA and pBB2::flhDC plasmids was analyzed. (B) Hemolytic activity of wild-type, shlB, rcsB, wecG, wecGrcsB, and flagellar-
mutant strains and the same strains carrying the empty vectors or pBB5::rcsB, pBB1::rcsB; pBB2::fliA, or pBB2::flhDCwas tested. (C)Hemolytic activity ofmutant
strains in Rcs system components, rcsB, rcsA, rcsF, and rcsC, was assayed. (D)Hemolytic activity from the phlA strain or the phlA rcsB or phlA shlB double-mutant
strain was assayed. The shlB strain was used as a control in panels A, B, andD. The values shown are themeans of at least three independent experiments, and the
error bars indicate standard deviations. (E) Immunodetection of the flagellin FliC. Whole-cell extracts from S. marcescens grown ON at 30°C were analyzed by
Western blotting with anti-flagellin polyclonal antibodies. The image is representative of at least three independent immunodetection assays.
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RcsB-His	6, as described inMaterials andMethods. As shown in
Fig. 5B, RcsB-His	6 protected an overlapping region fromnucle-
otide (nt) 249 to 265 relative to the shlB translational ATG
start site. This protected region overlaps the in silico-predicted
sequence that displays 12 matches to the RcsB consensus binding
motif (Fig. 5A). The RcsB protection within the predicted RcsB
motif in the promoter region of flhDC corroborated our previous
results (17) and indicated that the His	6 tag did not alter RcsB
functionality (Fig. 5A and B). We also explored the effect of the
phosphorylation status of RcsB on the ability of the regulator to
interact with DNA. For this purpose, when using the shlBA non-
coding strand, we performed the footprinting assay using RcsB,
either not treated or previously incubated with acetyl-phosphate,
as the phosphoryl donor (Fig. 5B, middle). Acetyl-phosphate-
treated RcsB exerted stronger protection than an equivalent con-
centration of untreated RcsB, indicating that the phosphorylated
response regulator displays higher affinity for its target site in the
shlBA promoter.
These results establish that RcsB is able to control the tran-
scriptional level of shlBA expression by direct interaction with a
specific recognition motif within the shlBA promoter region. In-
terestingly, a predictive in silico analysis of the shlBA promoter
region in search of a putative FliA DNA-binding motif by use of
the MEME/MAST motif detection programs (35, 36) showed a
consensus FliA box that partially overlaps the RcsB-bindingmotif
(Fig. 5C). Therefore, we propose an RcsB-dependent regulatory
circuit that is summarized in the scheme shown in Fig. 5D.
In light of these results, we also examined the impact of the
RcsB-dependent regulatory mechanism on the control of ShlA-
mediated induction of the autophagic process in epithelial cells.
With this aim, we coincubated S.marcescens strains (wild type and
mutants) with EGFP-LC3-CHO cells and scored the total number
of cells that showed LC3 puncta at 60 and 120min p.i. As shown in
Fig. 6A, at 120 min p.i., the induction of autophagy was increased
114% 10.5% in the rcsB backgroundwhile it was 65.9% 1.2%
diminished in the wecG mutant strain (RcsB-inducing condi-
tions), in good agreement with shlBA expression being transcrip-
tionally repressed by RcsB. The levels achieved by the doublewecG
rcsB strain were identical to the values obtained for the rcsB strain,
corroborating the role of RcsB in the transduction of the inducing
signal. Also in accordance with our previous results, a 26% 
7.5% reduction in the autophagic cell score compared to the wild-
type level was observed when the fliA or flhD strain was assayed.
Discrepancies between the magnitude of the inhibitory or induc-
ing effects determined for each strain when hemolytic activity lev-
els and autophagy scores were compared (Fig. 6A and 3) can be
attributed to differences in each assay’s conditions, to distinct
membrane peculiarities of the target cells, and/or to toxin dose
thresholds required to achieve each biological effect. Figure 6B
shows representative microscopic analysis of images captured
from the assay obtained at 60 and 120 min p.i. The exacerbated
EGFP-LC3 punctate pattern became evident when the rcsB or the
wecG rcsB strain was used (Fig. 6B, m to p), while the cells chal-
lenged with the fliA and flhD strains had an intermediate pheno-
type (Fig. 6B, e to h). shlB strain-exposed cells show no detectable
difference from untreated cells (Fig. 6B, compare c and d to e and
f). At 60 and 120 min p.i., the wecG strain (Fig. 6B, k and l) shows
a subtle autophagic phenotype (fine, scattered EGFP-LC3
puncta), which is consistent with the reduced shlBA transcrip-
tional and hemolytic activities measured for the strain (Fig. 3
and 4).
DISCUSSION
We previously established that S. marcescens could trigger a non-
canonical autophagic cascade from outside host epithelial cells
prior to the internalization process (4). In this work, we identify
the bacterial factor required for this induction as ShlA. To our
knowledge, this is the first report that shows a factor exported by a
bacterial two-partner secretion system that is responsible for the
onset of autophagy in eukaryotic cells. To confirm that ShlA is the
required factor, we showed that the capacity to promote au-
tophagy in epithelial cells could be conferred on a noninvasive E.
coli strain by the recombinant expression of the Serratia ShlB/ShlA
Tps system. However, taking together the facts that (i) bacterium-
free, filtered supernatants from Serratia growth culture are unable
to induce autophagy in CHO cells (data not shown) and (ii) the
purified-ShlA hemolytic-activity half-life is estimated to be 3 min
at 37°C (37), our results cannot rule out the possibility that an-
other bacterial product or structural component, shared by E. coli
and Serratia, might be involved in ShlA stabilization or in allowing
the pore-forming toxin to exert its action.
Recent reports support the hypothesis that pathogenic bacteria
that reside and/or proliferate inside intracellular vacuoles, such as
Shigella, Listeria, or Salmonella, induce the autophagic response
by affecting cellular metabolism (38, 39). This would be accom-
plished by promoting rapid depletion of the amino acid intracel-
lular pools that provoke mTOR kinase inhibition, which in turn
results in derepression of the autophagic process. Interestingly,
Tattoli et al. (38) showed that aseptic damage to the host plasma
membrane or lysosomes was sufficient to trigger amino acid star-
vation pathways, but only lysosomal damage resulted in mTOR
inhibition, arguing that the pathway is triggered only by bacteria
from within intracellular compartments. Indeed, the effectors re-
sponsible for autophagy induction identified in Listeria and Sal-
FIG 4 Influence of the flagellar regulatory cascade and the Rcs system over
shlBA transcriptional expression. Overnight cultures of the S. marcescens wt/
ppromshlBA-gfp, fliA/ppromshlBA-gfp, flhD/ppromshlBA-gfp, wecG/
ppromshlBA-gfp, and rcsB/ppromshlBA-gfp strains grown in LBmediumwere
diluted in fresh LBmediumand incubated in a 96-well blackmicrotiter plate at
30°C without agitation for 18 h. Fluorescence (exc 
 485 nm; em 
 528
nm) and OD600 readings were determined every 60 min, with a 96-microwell
Synergy2 or BioTek ELx808 microplate reader, respectively. The means and
standard deviations for three independent assays performed in duplicate in
each case were calculated. Statistical analysis was performed using one-way
ANOVA and the Tukey-Kramer multiple-comparison test. ***, P  0.001;
statistically significantly different from wild-type S. marcescens.
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monella, LLO- (38) and SPI-1-dependent factors (40), respec-
tively, were shown to damage the bacterium-containing vacuole
membrane.
Kloft et al. (28, 29) found that epithelial cell lines exposed to
diverse purified pore-forming toxins (Staphylococcus aureus al-
pha-toxin, Vibrio cholerae cytolysin, streptolysin O, or E. coli he-
molysin) activated pathways leading to autophagy. Later, Gonza-
lez et al. (41) added to this finding, showing analogous results with
LLO from Listeria monocytogenes and aerolysin from Aeromonas
hydrophila. Additionally, Byrne et al. (30) have shown that, in
macrophages, treatment with micromolar concentrations of the
inonophore valynomycin was sufficient to stimulate accumula-
tion of LC3 vacuoles. In sum, their assays showed that a drop in
the cellular ATP/AMP ratio, an increase in K efflux, and the
concomitant amino acid depletion caused by cell plasma mem-
brane disruption are the signals that are able to induce the au-
tophagic process by the activation of different transduction path-
ways. This induction promotes a quiescent state that favors
homeostasis recovery and repair of membrane damage to the in-
jured cell.
We previously established that, after internalization in
nonphagocytic cells, S. marcescens is able to reside and multiply
intracellularly inside autophagic-like vacuoles (4). The results
shown in this work indicate that when Serratia encounters the
host cell, autophagy induction takes place in two stages. The early
interaction with bacteria exposes epithelial cells to the action of
the ShlA pore-forming toxin. We can conjecture that the meta-
bolic imbalance, probably prompted by K efflux, generated by
ShlA-mediated damage would promote the observed autophagic
response in the vast majority of cells. Then, a comparatively small
percentage of cells are effectively invaded by Serratia. We previ-
ously demonstrated that early after internalization, Serratia estab-
lishes itself within a vacuole that recruits prototypical autophagic
markers, i.e., LC3 and Rab7 (4). Our results indicate that ShlA
FIG 5 RcsB binds to the promoter region of the S. marcescens shlBA and flhDC operons. (A) Logo showing the consensusmotif for the RcsB-binding site and the
predicted RcsB-binding site sequences in the promoter regions of S. marcescens (S.m.) flhDC and shlBA. (B) DNA footprinting analysis was performed on
end-labeled coding and noncoding strands of the shlB promoter region and on the noncoding strand for the flhDC promoter region. The DNA fragments were
incubated with purified RcsB-His	6 at a final concentration of 0 () or 400 pmol (*) or with acetyl-phosphate preincubated with RcsB-His	6 at a final
concentration of 400 pmol (). The positions of the protected areas were determined by comparison with sequence ladders obtained by using the same labeled
primer that was used as a probe. The RcsB-protected regions are indicated, with the respective nucleotide sequences. (C) Logo showing the consensus motif for
the FliA-binding site and the predicted FliA-binding site sequences in the promoter regions of S. marcescens shlBA. DNA-protected regions obtained by the DNA
footprinting assays are underlined (A), while the binding motifs that match the RcsB or FliA consensus motifs are indicated in boldface (C). (D) Schematic
overview of the RcsB-dependent regulatory circuit that governs shlBA expression. (Left) When RcsB is inactive (RcsB, nonphosphorylated RcsB protein), FliA
protein expression drives shlBA operon transcription by interaction with the FliA-bindingmotif within the shlBA operon promoter region (dashed arrow, shlBA
transcript). (Right)ActivatedRcsB (RcsBP, phosphorylatedRcsBprotein) represses the transcriptional activity of the flagellarflhDC-dependent transcriptional
cascade, inhibiting FliA expression, while it simultaneously downregulates shlBA transcription by direct interactionwith theRcsB-bindingmotif within the shlBA
operon promoter region.
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would not be required either for internalization into cells or for
recruitment of LC3 to the SeCV. Conceivably, Serratia effectors,
such as proteolytic or lipolitic exoenzymes, could be responsible
for damage to the endocytic vacuole, engaging the autophagic
machinery that contributes to shape SeCV features. Nevertheless,
whether wild-type SeCV vacuoles are identical to their hemolysin
mutant strain-containing counterparts should be further exam-
ined. In this context, our ongoing experiments focus on finding
out whether externally ShlA-triggered autophagy paves the way
for subsequent steps of successful Serratia internalization, estab-
lishment, and proliferation inside the SeCV.
Wehave previously shown thatmutations in genes coding for the
components of the Rcs signaling cascade counteract the defects in
Serratia flagellum-dependent motility inflicted by alterations in
the enterobacterial common antigen assembly. This finding led us
to demonstrate that in S. marcescens, RcsB inhibits the expression
of flhDC (16, 17). We have now confirmed direct binding of S.
marcescens RcsB to a conserved RcsB recognition motif within the
flhDC promoter region. This regulatory feature adds new evidence
about the conservation of RcsB as a repressor of the FlhDC-depen-
dent pathway among Enterobacteriaceae (14, 42). Additionally, we
show that the abrogation of either flhDC or fliA expression down-
regulates shlBA expression, indicating that downstream of FlhDC in
the hierarchical flagellar cascade, FliA induces shlBA expression. In
keeping with this result, overexpression of either FlhDC or FliA in a
wild-type genetic background induces shlBA expression. Together,
these results and the fact that a predicted conserved FliA-binding
motif is found by bioinformatics analysis upstreamof the shlBA cod-
ing region (Fig. 5C) strongly suggest that FliA is able to activate ShlA
expression by direct induction of shlBA transcription. FliA-mediated
regulation of ShlA expression also helps to explain the results ob-
tained by Soo et al. in an S. marcescensCH-1 pigmented strain (43)
showing that the RssAB system could partially repress shlBA in an
FlhDC-dependent manner.
FIG 6 Influence of the flagellar regulatory cascade and of RcsB over autophagy induction. CHO-EGFP-LC3 cells were infected with the S. marcescenswild-type,
shlB, flhD, fliA, wecG, rcsB, or wecG rcsB strain and fixed at the indicated time points. Intracellular bacteria were detected with anti-Serratia antibodies coupled
with a secondary antibody labeled with Cy3. (A) The percentages of cells containing LC3 puncta were determined by confocal microscopy. At least 300 cells were
counted for each condition. The averages and SD are shown for three independent experiments performed in duplicate in each case. Statistical analysis was
performed using one-way ANOVA and the Tukey-Kramer multiple-comparison test. **, P  0.01; ***, P  0.001; statistically significantly different from
wild-type S.marcescens. (B) Cells were visualized by confocal lasermicroscopy. (a and b) Representative images of control noninvaded cells. (c to p)Cells infected
with the S. marcescens wild-type (c and d), shlB (e and f), flhD (g and h), fliA (i and j), wecG (k and l), rcsB (m and n), or wecG rcsB (panels o and p) strain.
Representative DIC and merged images are shown. Bars, 10 m.
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The hierarchical control of the expression of a Tps-dependent
cytotoxin by the flagellar regulatory cascade has also been shown
for Proteus mirabilis hpmBA (44) and Xenorhabdus nematophila
xaxAB (45). We are tempted to speculate that this could be a
common regulatory feature for those opportunistic bacteria that
alternate between environmental and host-associated lifestyles,
such as Edwardsiella (46, 47), Erwinia, Photorhabdus, Pseudomo-
nas, and Xylella, which were found to carry ShlBA orthologues
encoded in their genomes (6, 48, 49). In S.marcescens, the fact that
ShlA is coupled with flagellum expression also argues in favor of
the conjecture that both bacterial determinants are required prior
to the internalization of the bacterium into host epithelial cells: the
flagellum operates as an attachment factor (4), while ShlA pro-
vokes transient membrane destabilization, a low energy con-
sumption status, and the onset of signaling pathways that might
favor later invasion steps.
Here, we show that shlBA expression is highly induced in an
rcsB mutant strain while it is severely repressed in a wecG mutant
in which the Rcs system is activated and demonstrate that RcsB is
able to recognize a conserved binding motif in the promoter re-
gion of the shlBA operon. These findings, together with the fact
that RcsB overexpression inhibits shlBA expression in either an
flhD or an fliA mutant background, reveal that RcsB is able to
downregulate shlBA expression in an FlhDC/FliA-independent
manner. In sum, we show that the expression of shlBA is subjected
to a transcriptional feed-forward regulatory circuit dependent on
RcsB that can involve or bypass the flagellar regulatory pathway.
No participation of canonical Rcs phosphorelay components
(RcsC, RcsA, and RcsF) was detected, suggesting either that non-
phosphorylated RcsB is proficient in downregulating shlBA ex-
pression and this action depends on RcsB intracellular levels or
that signaling molecules other that RcsC/RcsD/RcsF can channel
themessage onto RcsB, defining its phosphorylation status. Inter-
estingly, the identified RcsB box partially overlaps the predicted
FliA-binding motif (Fig. 5) within the shlBA regulatory region.
Additionally, we have previously demonstrated that under RcsB-
activating conditions, fliA expression is repressed (17).Our results
show that inactivation of FliA expression in the fliAmutant strain
reduces the hemolytic activity only by ca. 50% and that this cor-
relates with the reduced values of shlBA transcriptional activity
(the results are shown in Fig. 3 and 4). Further repression levels are
achieved by direct binding of RcsB to the DNA recognition motif.
This repression was observed when RcsB was overexpressed from
a plasmid or when the Rcs systemwas activated by the abolition of
ECA expression. Together, these results anticipate a scenario in
which, in response to environmental cues, the FliA-mediated in-
duction of shlBA expression can switch toRcsB-dependent repres-
sion, or vice versa, by occupancy replacement of one regulator by
the other in the DNA-binding region.
A phenotypical outcome from different settings of the regula-
tory circuit that controls ShlA expression was demonstrated by
autophagic induction in epithelial cells (Fig. 6). In light of these
results, we can also infer that this feed-forward regulatory path has
evolved to provide multiple access points for the fine-tuning of
ShlA expression, highlighting the functional importance of this
cytotoxin throughout the Serratia life cycle. In addition to the
regulation of flagellum and ShlA expression, we have previously
shown that S. marcescens RcsB is involved in controlling the pro-
duction of OMVs, which are vehicles for the delivery of virulence
factors (18). These findings define RcsB as one master regulator
that commands the expression ofmultiple phenotypes that endow
S. marcescens with its pathogenic potential. Together, this knowl-
edge provides new tools to design strategies to fight Serratia infec-
tions.
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